Neoplasm Malignant Clinical Trials in Milan
5 recruitingMilan, Italy
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Neoplasm Malignant
Merck Sharp & Dohme LLC150 enrolled46 locationsNCT07209111
Recruiting
Phase 2
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC60 enrolled34 locationsNCT06788912
Recruiting
Phase 2
Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer
Breast Neoplasm Malignant Female
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano152 enrolled1 locationNCT06938724
Recruiting
Not Applicable
Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy
Mastectomy, SegmentalBreast Neoplasm Malignant Female
Tensive SRL92 enrolled3 locationsNCT05941299
Recruiting
Not Applicable
Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
Gastrointestinal Neoplasm Malignant
Chinese Academy of Sciences400 enrolled7 locationsNCT06002425